On 17 September the FDA's Bone, Reproductive and Urologic Drugs panel will convene with the Drug Safety and Risk Management...
Repros Therapeutics reported top line results for the first of two identical pivotal studies comparing Androxal (clomiphene) to a leading...
Repros Therapeutics reported top line results from the second of two identical pivotal studies comparing Androxal to a leading FDA...
Clarus Therapeutics has presented Phase III clinical data from studies that support the safety and efficacy of Rextoro (testosterone undecanoate)...
52-week data for Tlando (LCPN 1021) from LipocineInc., were presented for the first time for during the 111th Annual Scientific...